SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-134503
Filing Date
2013-03-29
Accepted
2013-03-29 15:57:06
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d453679d10k.htm 10-K 1196632
2 EX-21.1 d453679dex211.htm EX-21.1 2014
3 EX-23.1 d453679dex231.htm EX-23.1 1451
4 EX-31.1 d453679dex311.htm EX-31.1 10228
5 EX-31.2 d453679dex312.htm EX-31.2 10232
6 EX-32.1 d453679dex321.htm EX-32.1 4572
7 EX-32.2 d453679dex322.htm EX-32.2 4562
  Complete submission text file 0001193125-13-134503.txt   11788997

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT galt-20121231.xml EX-101.INS 1360263
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20121231.xsd EX-101.SCH 109093
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20121231_cal.xml EX-101.CAL 56590
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20121231_def.xml EX-101.DEF 495367
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20121231_lab.xml EX-101.LAB 731363
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20121231_pre.xml EX-101.PRE 574157
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 13727758
SIC: 2834 Pharmaceutical Preparations